Cigna Group (NYSE:CI) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Cigna Group (NYSE:CI) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-two brokerages that are currently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $333.1053.

A number of brokerages have weighed in on CI. Truist Financial lifted their price target on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Sanford C. Bernstein raised shares of Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $307.00 to $358.00 in a research report on Thursday, March 12th. Robert W. Baird reduced their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. UBS Group reaffirmed a “buy” rating and set a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cigna Group in a research report on Monday, December 29th.

Insiders Place Their Bets

In other news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Cigna Group

Hedge funds and other institutional investors have recently bought and sold shares of the business. Brighton Jones LLC raised its holdings in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after acquiring an additional 318 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares in the last quarter. Cary Street Partners Investment Advisory LLC increased its position in shares of Cigna Group by 28.3% in the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 385 shares of the health services provider’s stock worth $127,000 after purchasing an additional 85 shares during the last quarter. Cerity Partners LLC increased its position in shares of Cigna Group by 0.6% in the 2nd quarter. Cerity Partners LLC now owns 94,708 shares of the health services provider’s stock worth $31,308,000 after purchasing an additional 562 shares during the last quarter. Finally, Baker Avenue Asset Management LP raised its stake in shares of Cigna Group by 14.2% in the 2nd quarter. Baker Avenue Asset Management LP now owns 981 shares of the health services provider’s stock valued at $324,000 after purchasing an additional 122 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Trading Down 0.6%

Shares of CI stock opened at $274.06 on Wednesday. The stock has a market cap of $72.22 billion, a price-to-earnings ratio of 12.36, a price-to-earnings-growth ratio of 0.94 and a beta of 0.26. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The firm’s 50 day moving average price is $276.17 and its two-hundred day moving average price is $278.76.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. Cigna Group’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the company posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were paid a dividend of $1.56 per share. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s payout ratio is presently 28.13%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.